Anti-diabetic cataract compounds and their uses

Details for Australian Patent Application No. 2007231488 (hide)

Owner NATIONAL RESEARCH COUNCIL OF CANADA

Inventors Mullick, Alaka; Magoon, Joanne; Konishi, Yasuo

Agent Griffith Hack

Pub. Number AU-A-2007231488

PCT Pub. Number WO2007/109882

Priority 60/785,345 24.03.06 US

Filing date 23 March 2007

Wipo publication date 4 October 2007

International Classifications

C07C 215/60 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 27/12 (2006.01) Drugs for disorders of the senses

Event Publications

6 November 2008 PCT application entered the National Phase

  PCT publication WO2007/109882 Priority application(s): WO2007/109882

10 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007231495-Reactor and reactor system for high temperature and high pressure reactions

2007231487-Biomarkers useful for diagnosing prostate cancer, and methods thereof